We are live on ! Find out more
HCA icon

HCA Healthcare

962 hedge funds and large institutions have $43.3B invested in HCA Healthcare in 2022 Q4 according to their latest regulatory filings, with 176 funds opening new positions, 289 increasing their positions, 375 reducing their positions, and 69 closing their positions.

New
Increased
Maintained
Reduced
Closed

155% more first-time investments, than exits

New positions opened: 176 | Existing positions closed: 69

52% more funds holding in top 10

Funds holding in top 10: 2741 (+14)

28% more capital invested

Capital invested by funds: $33.8B → $43.3B (+$9.42B)

11% more funds holding

Funds holding: 868962 (+94)

0.92% less ownership

Funds ownership: 64.55%63.64% (-0.92%)

8% less call options, than puts

Call options by funds: $463M | Put options by funds: $503M

23% less repeat investments, than reductions

Existing positions increased: 289 | Existing positions reduced: 375

Holders
962
Holders Change
+94
Holders Change %
+10.83%
% of All Funds
15.46%
Holding in Top 10
41
Holding in Top 10 Change
+14
Holding in Top 10 Change %
+51.85%
% of All Funds
0.66%
New
176
Increased
289
Reduced
375
Closed
69
Calls
$463M
Puts
$503M
Net Calls
-$40.7M
Net Calls Change
+$67.1M
Name Holding Trade Value Shares
Change
Change in
Stake
Holocene Advisors
151
Holocene Advisors
New York
$23.7M -$27.3M -121,740 -55%
GIA
152
Gateway Investment Advisers
Ohio
$23.4M -$2.22M -9,904 -9%
TAM
153
Todd Asset Management
Kentucky
$23.1M -$1.53M -6,818 -7%
GF
154
Gabelli Funds
New York
$23M -$3.89M -17,380 -15%
Asset Management One
155
Asset Management One
Japan
$22.3M -$1.45M -6,469 -7%
Zurich Cantonal Bank
156
Zurich Cantonal Bank
Switzerland
$22.2M +$10.8M +48,436 +109%
Alyeska Investment Group
157
Alyeska Investment Group
Illinois
$22.2M -$25M -111,785 -55%
PHS
158
PFM Health Sciences
California
$22.1M -$18.7M -83,290 -48%
RPAM
159
Rhenman & Partners Asset Management
Sweden
$21.6M +$10.5M +47,000 +109%
GI
160
GAMCO Investors
Connecticut
$21.2M -$292K -1,304 -1%
LPL Financial
161
LPL Financial
California
$21M -$180K -802 -0.9%
VOYA Investment Management
162
VOYA Investment Management
Georgia
$20.7M -$128K -571 -0.7%
Natixis Advisors
163
Natixis Advisors
Massachusetts
$20.6M -$6.15M -27,449 -24%
PCH
164
Polar Capital Holdings
United Kingdom
$20.2M -$837K -3,736 -4%
CS
165
Candriam SCA
Luxembourg
$20.2M -$7.8M -34,829 -29%
AT
166
AMF Tjänstepension
Sweden
$19.9M
FAF
167
Första AP-fonden
Sweden
$19.5M -$26.8M -119,700 -60%
DekaBank Deutsche Girozentrale
168
DekaBank Deutsche Girozentrale
Germany
$18.7M -$34.3K -153 -0.2%
DMIC
169
Dixon Mitchell Investment Counsel
British Columbia, Canada
$18.7M +$576K +2,574 +3%
VRS
170
Virginia Retirement Systems
Virginia
$18.2M +$157K +700 +0.9%
Teacher Retirement System of Texas
171
Teacher Retirement System of Texas
Texas
$18M -$5.47M -24,415 -25%
RC
172
RBF Capital
California
$18M
Mariner
173
Mariner
Kansas
$17.6M -$930K -4,154 -5%
SAM
174
Storebrand Asset Management
Norway
$17.2M
Nisa Investment Advisors
175
Nisa Investment Advisors
Missouri
$17.2M -$10.1K -45 -0.1%

HCA Hedge Fund Activity: Q4 2022 in Review

962 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in HCA Healthcare (HCA) for Q4 2022, worth a combined $43.3B — up 28% from $33.8B a quarter earlier.

Buyers outnumbered sellers: 176 funds opened new HCA positions and 69 closed out — a net gain of 107 holders — while 289 added to existing stakes and 375 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $388M. The largest seller was Fidelity Investments, cutting an estimated $533M.

  • 962 institutional investors held HCA Healthcare (HCA) as of Q4 2022, up from 868 in Q3 2022.
  • Funds reported $43.3B of HCA Healthcare stock for Q4 2022, up 28% quarter-over-quarter.
  • 176 funds opened new HCA Healthcare positions in Q4 2022 and 69 closed out, a net change of +107 holders.
  • The largest HCA Healthcare buyer in Q4 2022 was T. Rowe Price Associates, an estimated $388M added.
  • The largest HCA Healthcare seller in Q4 2022 was Fidelity Investments, an estimated $533M sold.

Based on aggregated 13F filings for Q4 2022.